Therapeutic Goods Regulations (Amendment) (Cth)
__________________
I, The Governor-General of the Commonwealth of Australia, acting with the advice of the
Federal Executive Council, make the following Regulations under the
Dated 7 March 1995.
BILL HAYDEN
Governor-General
By His Excellency’s Command,
ROSEMARY CROWLEY
Minister for Family Services
____________
1.1 The Therapeutic Goods Regulations are amended as set out in these Regulations.
[NOTE: These Regulations commence on gazettal: see
2.1 After subregulation (1A), insert:
Item 6 in Schedule 5A ceases to apply at the end of 29 February 1996.”.
3.1 Add at the end:
“6 | Anti-D immunoglobulin | (a) | by Commonwealth Serum Laboratories Limited (“CSL”) from Orthodiagnostic Systems Inc. (“OSI”) in the United States of America; and | ||||
(b) | supply of the product in Australia must be by, or on behalf of, CSL; and | ||||||
(c) | when supplied to the patient, the product must have with it: | ||||||
(i) | of the conditions under which its importation was permitted; and | ||||||
(ii) | a copy of the Product Information, applicable to the product, that is published by OSI and approved by the United States Food and Drug Administration; and | ||||||
(d) | the patient must give to the treating medical practitioner, in writing, adequately informed consent to the administration of the product; and | ||||||
(e) | the treating medical practitioner must retain the written consent of the patient”. | ||||||
____________________________________________________________
1. Notified in the
Commonwealth of Australia Gazette on 8 March 1995.2. Statutory Rules 1990 No. 394 as amended by 1991 Nos. 84 and 485; 1992 Nos. 19, 89, 109, 332, 370 and 430; 1993 No. 141; 1994 Nos. 150, 222 and 364.
0
0
0